Skip to content
‹ Back to IndustriesSciences

Virgin Galactic Holdings CEO Michael Colglazier on Space Test Flights

Virgin Galactic Holdings’ recent successful launch rocketed confidence in the viability of commercial space travel. Watch below to see CEO Michael Colglazier react to the launch and comment on efforts to move towards commercial space tourism. Colglazier: We had three big points we were trying to do in this test flight, the first was to…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · BloombergCommercial Space TravelMichael ColglazierSpace
Share

Key takeaways

01

Virgin Galactic Holdings’ recent successful launch rocketed confidence in the viability of commercial space travel.

02

Watch below to see CEO Michael Colglazier react to the launch and comment on efforts to move towards commercial space tourism.

03

Colglazier: We had three big points we were trying to do in this test flight, the first was to…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Virgin Galactic Holdings’ recent successful launch rocketed confidence in the viability of commercial space travel. Watch below to see CEO Michael Colglazier react to the launch and comment on efforts to move towards commercial space tourism.

Colglazier: We had three big points we were trying to do in this test flight, the first was to test a new set of digital controllers that we have for the pilots, give them tighter steering. It worked flawlessly. It went really well as it curved just straight up into space and beautiful flight. Second thing we were doing was to ensure that we had the electromagnetic interference issue from earlier in the year and all the work that we had done on that completely eliminated that problem for us. And then finally, we collected data that we sent over to the FAA and we believe that will give us a great opportunity for them to analyze it, and then hopefully clear our license for commercial flights. So, all in all, just a beautiful day.

Host: Michael, it’s Guy in London. So what’s the journey between now and that points that license being achieved? What needs to happen? When’s the next flight? And what sort of milestones does that. Next slide have to achieve?

Colglazier: Sure well, this was our third flight to space with humans, the first from the state of New Mexico, which is a beautiful, beautiful place to look back down upon the planet. And what follows next. We have three more flights in our test flight program. Our next one will come up with a full crew of mission specialists and back. In addition to our two pilots, that one will be followed with a repeat. But we’re asking our founder, Richard Branson, to come on and really test the private astronaut experience for us. We think, who better to do that? And both of those, we expect to happen this summer. And then that will be followed by our final test flight that’s planned with the Italian Air Force really showcasing how our space systems used for microgravity science research as well as professional astronaut training. And we think that will likely happen late summer or early fall.

Host: So let’s get to that in terms of the preflight training. So we’re going back and forth on this. How healthy do you have to be? What kind of training does there have to be for a regular person to eventually book a flight on this?

Colglazier: So what’s really unique about Virgin Galactic is we take the first 50,000 feet or so with airplane technology. So we take off horizontally and our mother ship climbs out to 40, 45, 50,000 feet. And then from there, the spaceship drops and then rockets up. So it’s powerful, but reasonably smooth because we’ve gone through the heaviest part of the atmosphere, just like you would in a commercial airliner. It’s really important to stay fit in general, but it’s not something that needs years and years of training. So we recommend people stay flexible because they want to be moving around in a weightless environment and kind of looking out all the windows. But generally, we think as long as people are taking care of themselves, lots and lots and lots of people will be able to go with us.

Host: OK, so not much training, Alex was concerned that I was getting a little bit old, maybe I was working so hard to think about. Let’s talk about price. In terms of this venture going forward, Michael. This is a question that I’m surprised I’m asking, but I guess we’ve got to think about it going forward, what is the path to profitability? When do you think this is profitable? Once it starts getting up and running and you kind of get through the initial kind of phase on this and this becomes more commonplace. You got to be making money off this. When do you think you’re going to be making money off this?

Colglazier: Well, the first thing we need to do, obviously, finish this test flight program. And then move into commercial service. And we believe this is going to be a supply constrained business for quite some time. The demand of this is going to be well out in front of our ability to build and scale the fleet up for a while. And as such, it will be reasonably expensive as it goes forward. Our previous 600 people generally had a price around $250,000 each. We have not announced what our pricing will be going forward. We said it will be higher in the beginning. We do see pricing of around $600,000 for per seat equivalent for our microgravity research flights. But again, we have not put pricing out for the private astronaut market.

*Bloomberg contributed to this content

—

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Video TranscriptExpand ↓

We had three big points we were trying to do in this test flight, the first was to test a new set of digital controllers that we have for the pilots, give them tighter steering. It worked flawlessly. It went really as it curved just straight up into space and beautiful flight. Second thing we were doing was to ensure that we had the electromagnetic interference issue that had the latest from earlier in the year and all the work that we had done on that completely eliminated that problem for us. And then finally, we collected data that we sent over to the FAA and we believe that will give us a great opportunity for them to analyze it, and then hopefully clear our license for commercial flights. So, all in all, just a beautiful day. Michael, it's guy in London. So what's the journey between now and that points that license being achieved? What needs to happen? When's the next flight? What does that. And what sort of milestones does that. Next slide have to achieve? Sure well, this was our third flight to space with humans, the first from the state of New Mexico, which is a beautiful, beautiful place to look back down upon the planet. And what follows next. We have three more flights in our test flight program. Our next one will come up with a full crew of mission specialist and back. In addition to our two pilots, that one will be followed with a repeat. But we're asking our founder, Richard Branson, to come on and really test the private astronaut experience for us. We think, who better to do that? And both of those, we expect to happen this summer. And then that will be followed by our final test flight that's planned with the Italian Air Force really showcasing how our space systems used for microgravity science research as well as professional astronaut training. And we think that will likely happen late summer or early fall. So let's get to that in terms of the preflight training. So we're going back and forth on this. How healthy do you have to be? What kind of training does there have to be for a regular person to eventually book a flight on this? So what's really unique about Virgin Galactic is we take the first $50,000 feet or so with Airplane technology, so we take off horizontally and our mother ship climbs out to 40, 45, 50,000 feet. And then from there, the spaceship drops and then rockets up. So it's powerful, but reasonably smooth because we've gone through the heaviest part of the atmosphere, just like you would in a commercial airliner. It's really important to stay fit in general, but it's not something that needs unique years and years of training. So we recommend people stay flexible because they want to be moving around in a weightless environment and kind of looking out all the windows. But generally, we think as long as people are taking care of themselves, lots and lots and lots of people will be able to go with us. OK, so not much training, Alex was concerned that I was getting a little bit old, maybe I was working so hard to think about. Let's talk about price in terms of this venture going forward, Michael. This is a question that I'm surprised I'm asking, but I guess we've got to think about it going forward, what is the path to profitability? When do you think this is profitable? Once it starts getting up and running and you kind of get through the initial kind of phase on this and this becomes more commonplace. You got to be making money off this. When do you think you're going to be making money off this? Well, the first thing we need to do, obviously, finish this test flight program. And then move into commercial service. And we believe this is going to be a supply constrained business for quite some time. The demand of this is going to be well out in front of our ability to build and scale the fleet up for a while. And as such, it will be reasonably expensive as it goes forward. Our previous 600 people generally had a price around 250,000 each. We have not announced what our pricing will be going forward. We said it will be higher in the beginning. We do see pricing of around $600,000 for per seat equivalent for our microgravity research flights. But again, we have not put pricing out for the private astronaut market.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu names digitalization, personalization and large-volume delivery as the trends reshaping drug delivery devices, arguing structured data can end rebuilding design files for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of the injectable pipeline.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers University of Technology's AI scientist Eve analyzed about 60,000 public yeast records, came up with almost 2,000 testable ideas, and took full charge of planning the experiments and telling other robots what to do, according to CORDIS. Humans handled safety checks and plate moving.

  • 01The key step for company labs is translation: turning hypotheses into machine-executable protocols and getting contextualized results back to the reasoning layer fast.

Oct 19, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512